安序源生物科技（苏州）有限公司

Anxuyuan founded on April 7, 2020, it is a wholly-owned subsidiary of AXBIO.INC in the United States. American AXBIO.INC company was founded by a number of Silicon Valley serial entrepreneurs, multinational group executives, senior engineers and scientists. Its professional fields cover chip development, nanotechnology, microfluidics, biotechnology, bioinformatics, big data, artificial intelligence, etc. , And received capital injection from the world's top venture capital institutions. The company successfully developed a microfluidic Bio-CMOS platform capable of high-throughput sequencing and molecular diagnosis. The versatility of the platform makes it possible to manufacture a wide range of systems, from low-cost handheld devices for bedside diagnostics and consumers to fully automated instruments for use in independent laboratories and hospitals.